Respiratory News and Research

RSS

Major gaps persist in workplace protection against TB, HIV and hepatitis in South Africa

A large-scale survey of South African healthcare workers has revealed major gaps in workplace protection against tuberculosis, HIV and hepatitis, according to a University of British Columbia health researcher.

16 Feb 2014

Teleflex announces launch of Rusch DispoLED Single-Use Fiber Optic Laryngoscope Handle

Teleflex Incorporated, a leading global provider of medical devices for critical care and surgery, has announced the launch of the Rusch® DispoLED™ Single-Use Fiber Optic Laryngoscope Handle — a cost-neutral way to combat cross-contamination infection risk during intubation.

14 Feb 2014

Researcher seeks best way to obtain parental consent for research regarding newborn resuscitation

For years, obtaining parental consent for clinical research regarding newborn resuscitation in the delivery room has been a challenge. Now, a Saint Louis University pediatric researcher is asking new mothers and pregnant women when doctors should seek parental permission to allow medical research related to delivery room treatments.

14 Feb 2014

Prothelia, University of Nevada, Reno and Alexion partner to develop Laminin-111 for MDC1A

Prothelia Incorporated and University of Nevada, Reno announce that they have entered into strategic agreements with Alexion for the development of Laminin-111, a patented experimental protein replacement therapy for merosin-deficient congenital muscular dystrophy (MDC1A), a life-threatening, ultra-rare disease caused by a genetic deficiency of the Laminin-211 protein.

13 Feb 2014

FDA grants full approval of SYNRIBO for injection

Teva Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration has granted full approval of SYNRIBO (omacetaxine mepesuccinate) for injection. This oncology portfolio product received an accelerated approval in October, 2012 with additional clinical trial data required to fulfill post marketing requirements set forth by the FDA.

13 Feb 2014

Alvogen launches Inflectra into Central and Eastern Europe

Alvogen, the multinational pharmaceuticals company, today announced the launch of Inflectra (Infliximab) into Central and Eastern Europe. Inflectra, Europe's first biosimilar monoclonal antibody (mAb) therapy that has been approved for the treatment of inflammatory conditions including rheumatoid arthritis (RA), ankylosing spondylitis, Crohn's disease (CD), ulcerative colitis (UC), psoriatic arthritis (PsA) and psoriasis.

13 Feb 2014

International study examines link between infections and ischemic stroke in children

Common infections are associated with a significantly higher chance of stroke in children, but routine vaccinations may help decrease risk, according to preliminary research (abstract 39) presented at the American Stroke Association's International Stroke Conference 2014.

12 Feb 2014

Microbiologists find way to use statins to fight Hantavirus

wo Perelman School of Medicine microbiologists may have found a way to use statins, the well-known blockbuster cholesterol-lowering drugs, to fight the hantavirus, a mysterious and lethal microorganism that appeared suddenly in the US southwest over 20 years ago.

12 Feb 2014

Researchers demonstrate new approach to treating muscular dystrophy

Researchers at Washington University School of Medicine in St. Louis have demonstrated a new approach to treating muscular dystrophy. Mice with a form of this muscle-weakening disease showed improved strength and heart function when treated with nanoparticles loaded with rapamycin, an immunosuppressive drug recently found to improve recycling of cellular waste.

12 Feb 2014

Jazz Pharmaceuticals' Versacloz now commercially available in the U.S. for schizophrenia

Jazz Pharmaceuticals plc today announced U.S. commercial availability of Versacloz (clozapine, USP) oral suspension, the first and only oral suspension clozapine for severely ill treatment-resistant schizophrenia patients or those at risk of recurrent suicidal behavior with schizophrenia or schizoaffective disorder.

11 Feb 2014

Walgreens collaborates with NMAC to improve treatment outcomes for African Americans with HIV

In collaboration with the National Minority AIDS Council, Walgreens is furthering its commitment to improve HIV treatment outcomes for African Americans living with HIV by deepening pharmacists' training and expanding access to the pneumococcal vaccination specifically indicated for persons living with HIV as incidents of flu and pneumonia rise.

11 Feb 2014

Ario Pharma begins XEN-0501 Phase IIa study for treatment persistent cough in COPD patients

Ario Pharma Ltd, the Cambridge biopharmaceutical company developing innovative new approaches to treat respiratory disease, announced today that it has commenced a Phase IIa study of its TRPV1 antagonist, XEN-0501, for the treatment and prevention of cough in patients with chronic obstructive pulmonary disease (COPD). Persistent cough in COPD and other respiratory conditions present as a huge unmet medical need, with novel therapies urgently needed to improve the quality of life of patients.

11 Feb 2014

Zoetis reports revenue of $1.25 billion for Q4 2013

Zoetis Inc. today reported its financial results for the fourth quarter and full year 2013. The company reported revenue of $1.25 billion for the fourth quarter of 2013, an increase of 7% from the fourth quarter of 2012. Revenue reflected an operational increase of 9%, with foreign currency having a negative impact of 2 percentage points.

11 Feb 2014

Unvaccinated flu patients need more intensive care

A snapshot of patients who required care at Duke University Hospital during this year's flu season shows that those who had not been vaccinated had severe cases and needed the most intensive treatment.

11 Feb 2014

Researchers promote scientific and health prevention culture among national population

The Mexican enterprise "Science that breathes" is supported by the National Institutes of Respiratory Diseases and Carcinology among others.

11 Feb 2014

Air pollution puts pressure on primary care

Research in Hong Kong shows that air pollution concentrations are significantly associated with the number of consultations for upper respiratory tract infections (URTIs), contributing to the burden on primary care services.

10 Feb 2014

Scientists identify factors that predict flu severity in patients

St. Jude Children's Research Hospital scientists have identified a signature immune response that might help doctors identify which newly diagnosed influenza patients are most likely to develop severe symptoms and suffer poor outcomes. The findings also help explain why infants and toddlers are at elevated risk for flu complications. The research appears in the upcoming issue of the American Journal of Respiratory and Critical Care Medicine.

10 Feb 2014

Respiratory News and Research

Major gaps persist in workplace protection against TB, HIV and hepatitis in South Africa

Teleflex announces launch of Rusch DispoLED Single-Use Fiber Optic Laryngoscope Handle

Researcher seeks best way to obtain parental consent for research regarding newborn resuscitation

Prothelia, University of Nevada, Reno and Alexion partner to develop Laminin-111 for MDC1A

FDA grants full approval of SYNRIBO for injection

Alvogen launches Inflectra into Central and Eastern Europe

International study examines link between infections and ischemic stroke in children

Microbiologists find way to use statins to fight Hantavirus

Researchers demonstrate new approach to treating muscular dystrophy

Jazz Pharmaceuticals' Versacloz now commercially available in the U.S. for schizophrenia

Walgreens collaborates with NMAC to improve treatment outcomes for African Americans with HIV

Ario Pharma begins XEN-0501 Phase IIa study for treatment persistent cough in COPD patients

Zoetis reports revenue of $1.25 billion for Q4 2013

Unvaccinated flu patients need more intensive care

Researchers promote scientific and health prevention culture among national population

Air pollution puts pressure on primary care

Scientists identify factors that predict flu severity in patients

Finding could lead to first effective vaccine against respiratory syncytial virus

Infection contributes to higher risk of stroke death among blacks

Loyola University toxicologist to talk about rise seen in heroin overdoses in recent years

Industry Focus eBook - Cell biology (5th edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News